Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling

Molecular Endocrinology

Volumn 21, Issue 4, 2007, Pages 783-796

  Gibbons, Carrie ^a   Dackor, Ryan ^a,b   Dunworth, William ^a,b   Fritz Six, Kimberly ^a   Caron, Kathleen M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ANGIOPOIETIN; GHRELIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN; SIGNAL PEPTIDE;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; EMBRYO DEVELOPMENT; EXPERIMENTAL MODEL; FEMALE FERTILITY; GENE EXPRESSION; GENETIC MODEL; GENOMICS; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOXIA; KIDNEY FAILURE; MICROARRAY ANALYSIS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SECOND MESSENGER; SEPSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANIMAL MODEL; BLOOD; GENERAL ASPECTS OF DISEASE; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ADRENOMEDULLIN; ANIMALS; DISEASE; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MODELS, ANIMAL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 34247850802     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0156     Document Type: Short Survey

References (114)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T 1993 Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
2. Muff R, Born W, Fischer JA 1995 Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133:17-20
3. Wimalawansa SJ 1997 Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239
4. Foord SM, Topp SD, Abramo M, Holbrook JD 2005 New methods for researching accessory proteins. J Mol Neurosci 26:265-276
5. Caron KM, Smithies O 2001 Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci USA 98:615-619
6. Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang Y, Morita H, Imai Y, Kayaba Y, Nishimatsu H, Suematsu , Hirata Y, Yazaki Y, Nagai R, Kuwaki T, Kurihara H 2001 Elevated sympathetic nervous activity in mice deficient in αCGRP. Circ Res 89:983-990
7. Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB 1999 Mice lacking α-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 14:99-120
8. Ogoshi M, Inoue K, Takei Y 2003 Identification of a novel adrenomedullin gene family in teleost fish. Biochem Biophys Res Commun 311:1072-1077
9. Garayoa M, Bodegas E, Cuttitta F, Montuenga LM 2002 Adrenomedullin in mammalian embryogenesis. Microsc Res Tech 57:40-54
10. Hinson JP, Kapas S, Smith DM 2000 Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138-167
11. Elsasser TH, Kahl S, Martinez A, Montuenga LM, Pio R, Cuttitta F 1999 Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinology 140:4908-4911
12. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, Elsasser TH, Cuttitta F 2001 Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276:12292-12300
13. Lisy O, Jougasaki M, Schirger JA, Chen HH, Barclay PT, Burnett Jr JC 1998 Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin. Am J Physiol 275:F410-F414
14. Dupuis J, Caron A, Ruel N 2005 Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin. Clin Sci (Lond) 109:97-102
15. Lopez J, Martinez A 2002 Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 221:1-92
16. Yanagawa B, Nagaya N 2007 Adrenomedullin: molecular mechanisms and its role in cardiac disease. Amino Acids 32: 157-164
17. Brain SD, Grant AD 2004 Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903-934
18. Del Bene R, Lazzeri C, Barletta G, Vecchiarino S, Guerra CT, Franchi F, La Villa G 2000 Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man. Clin Physiol 20:457-465
19. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K 2000 Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498-503
20. Oya H, Nagaya N, Furuichi S, Nishikimi T, Ueno K, Nakanishi N, Yamagishi M, Kangawa K, Miyatake K 2000 Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure. Am J Cardiol 86:94-98
21. Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM, Nicholls MG 1997 Adrenomedullin: a hypotensive hormone in man. Clin Sci (Lond) 92:467-472
22. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG 2000 Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab 85:1016-1020
23. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR 1997 Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 82:95-100
24. Khan AI, Kato J, Kitamura K, Kangawa K, Eto T 1997 Hypotensive effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 24:139-142
25. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T 1993 Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241:271-273
26. Cheng DY, DeWitt BJ, Wegmann MJ, Coy DH, Bitar K, Murphy WA, Kadowitz PJ 1994 Synthetic human adrenomedullin and ADM15-52 have potent short-lasting vasodilator activity in the pulmonary vascular bed of the cat. Life Sci 55:PL251-PL256
27. Kato T, Bishop AT, Wood MB 1996 Effect of human adrenomedullin on a canine tibial perfusion model in the absence of vascular endothelium. J Orthop Res 14:956-961
28. Hjelmqvist H, Keil R, Mathai M, Hubschle T, Gerstberger R 1997 Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am J Physiol 273:R716-R724
29. Westphal M, Stubbe H, Bone HG, Daudel F, Vocke S, Van Aken H, Booke M 2002 Hemodynamic effects of exogenous adrenomedullin in healthy and endotoxemic sheep. Biochem Biophys Res Commun 296:134-138
30. Beltowski J, Jamroz A 2004 Adrenomedullin - what do we know 10 years since its discovery? Pol J Pharmacol 56:5-27
31. Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJ 2004 The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther 103:179-201
32. Perret M, Broussard H, LeGros T, Burns A, Chang JK, Summer W, Hyman A, Lippton H 1993 The effect of adrenomedullin on the isolated heart. Life Sci 53:PL377-PL379
33. Szokodi I, Kinnunen P, Ruskoaho H 1996 Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol Scand 156:151-152
34. Stangl V, Dschietzig T, Bramlage P, Boye P, Kinkel HT, Staudt A, Baumann G, Felix SB, Stangl K 2000 Adrenomedullin and myocardial contractility in the rat. Eur J Pharmacol 408:83-89
35. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, Eto T 1998 Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 31:505-510
36. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K 1999 Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur J Pharmacol 382:1-9
37. Kato J, Tsuruda T, Kitamura K, Eto T 2003 Adrenomedullin: a possible autocrine or paracrine hormone in the cardiac ventricles. Hypertens Res 26(Suppl):S113-S119
38. Nishikimi T, Matsuoka H 2005 Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr Med Chem Cardiovasc Hematol Agents 3:231-242
39. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees MC 1998 PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 16:409-415
40. Nguyen SV, Claycomb WC 1999 Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 265:382-386
41. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Krull M, Seybold J, Seeger W, Rascher W, Schutte H, Suttorp N 2002 Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91:618-625
42. Zudaire E, Martinez A, Cuttitta F 2003 Adrenomedullin and cancer. Regul Pept 112:175-183
43. Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R 2006 Adrenomedullin and tumour angiogenesis. Br J Cancer 94:1-7
44. Serrano J, Alonso D, Fernandez AP, Encinas JM, Lopez JC, Castro-Blanco S, FernandezVizarra P, Richard A, Santacana M, Uttenthal LO, Bentura ML, Martinez-Murillo R, Martinez A, Cuttitta F, Rodrigo J 2002 Adrenomedullin in the central nervous system. Microsc Res Tech 57:76-90
45. Mukoyama M, Sugawara A, Nagae T, Mori K, Murabe H, Itoh H, Tanaka I, Nakao K 2001 Role of adrenomedullin and its receptor system in renal pathophysiology. Peptides 22:1925-1931
46. Brogden KA, Guthmiller JM, Salzet M, Zasloff M 2005 The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 6:558-564
47. Eva C, Sprengel R 1993 A novel putative G protein-coupled receptor highly expressed in lung and testis. DNA Cell Biol 12:393-399
48. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y 1996 A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271:11325-11329
49. Han ZQ, Coppock HA, Smith DM, Van Noorden S, Makgoba MW, Nicholl CG, Legon S 1997 The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol 18:267-272
50. Harrison JK, Barber CM, Lynch KR 1993 Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver. FEBS Lett 318:17-22
51. Kapas S, Catt KJ, Clark AJ 1995 Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 270:25344-25347
52. Kapas S, Clark AJ 1995 Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem Biophys Res Commun 217:832-838
53. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
54. Julian M, Cacho M, Garcia MA, Martin-Santamaria S, de Pascual-Teresa B, Ramos A, Martinez A, Cuttitta F 2005 Adrenomedullin: a new target for the design of small molecule modulators with promising pharmacological activities. Eur J Med Chem 40:737-750
55. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W 2000 Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420-423
56. Doods H 2001 Development of CGRP antagonists for the treatment of migraine. Curr Opin Investig Drugs 2:1261-1268
57. Moreno MJ, Abounader R, Hebert E, Doods H, Hamel E 2002 Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology 42:568-576
58. Hay DL, Poyner DR, Sexton PM 2006 GPCR modulation by RAMPs. Pharmacol Ther 109:173-197
59. Sexton PM, Albiston A, Morfis M, Tilakaratne N 2001 Receptor activity modifying proteins. Cell Signal 13:73-83
60. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM 1999 Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56:235-242
61. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, Sexton PM 2003 Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278:3293-3297
62. Bouschet T, Martin S, Henley JM 2005 Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 118:4709-4720
63. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso RM, Mogrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB 2002 Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465-4470
64. Steiner S, Muff R, Gujer R, Fischer JA, Born W 2002 The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor. Biochemistry 41:11398-11404
65. Zumpe ET, Tilakaratne N, Fraser NJ, Christopoulos G, Foord SM, Sexton PM 2000 Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Biochem Biophys Res Commun 267:368-372
66. Fraser NJ, Wise A, Brown J, McLatchie LM, Main MJ, Foord SM 1999 The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Pharmacol 55:1054-1059
67. Kuwasako K, Kitamura K, Nagoshi Y, Cao YN, Eto T 2003 Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J Biol Chem 278:22623-22630
68. Kuwasako K, Cao YN, Chu CP, Iwatsubo S, Eto T, Kitamura K 2006 Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 281:7205-7213
69. Bomberger JM, Spielman WS, Hall CS, Weinman EJ, Parameswaran N 2005 Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J Biol Chem 280:23926-23935
70. Bomberger JM, Parameswaran N, Hall CS, Aiyar N, Spielman WS 2005 Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J Biol Chem 280:9297-9307
71. Hay DL, Howitt SG, Conner AC, Doods H, Schindler M, Poyner DR 2002 A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. Br J Pharmacol 137:80-86
72. Kuwasako K, Cao YN, Nagoshi Y, Kitamura K, Eto T 2004 Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides 25:2003-2012
73. Udawela M, Hay DL, Sexton PM 2004 The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol 15:299-308
74. Thota C, Yallampalli C 2005 Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3′5′-monophosphate generation in Eker rat uterine smooth muscle cell line. Biol Reprod 72:416-422
75. Gangula PR, Thota C, Wimalawansa SJ, Bukoski RD, Yallampalli C 2003 Mechanisms involved in calcitonin gene-related peptide-induced relaxation in pregnant rat uterine artery. Biol Reprod 69:1635-1641
76. Dong YL, Vegiraju S, Chauhan M, Yallampalli C 2003 Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization. Mol Hum Reprod 9:481-490
77. Dong YL, Green KE, Vegiragu S, Hankins GD, Martin E, Chauhan M, Thota C, Yallampalli C 2005 Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab 90:2336-2343
78. Knerr I, Dachert C, Beinder E, Metzler M, Dotsch J, Repp R, Rascher W 2002 Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 101:47-53
79. Makino Y, Shibata K, Makino I, Kangawa K, Kawarabayashi T 2001 Alteration of the adrenomedullin receptor components gene expression associated with the blood pressure in pregnancy-induced hypertension. J Clin Endocrinol Metab 86:5079-5082
80. Hewitt SC, Collins J, Grissom S, Deroo B, Korach KS 2005 Global uterine genomics in vivo: microarray evaluation of the estrogen receptor α-growth factor crosstalk mechanism. Mol Endocrinol 19:657-668
81. Watanabe H, Takahashi E, Kobayashi M, Goto M, Krust A, Chambon P, Iguchi T 2006 The estrogen-responsive adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor. J Mol Endocrinol 36:81-89
82. Ikeda K, Arao Y, Otsuka H, Kikuchi A, Kayama F 2004 Estrogen and phytoestrogen regulate the mRNA expression of adrenomedullin and adrenomedullin receptor components in the rat uterus. Mol Cell Endocrinol 223:27-34
83. Ono Y, Okano I, Kojima M, Okada K, Kangawa K 2000 Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun 271:197-202
84. Ornan DA, Chaudry IH, Wang P 2002 Saturation of adrenomedullin receptors plays an important role in reducing pulmonary clearance of adrenomedullin during the late stage of sepsis. Biochim Biophys Acta 1586:299-306
85. Ornan DA, Chaudry IH, Wang P 1999 Pulmonary clearance of adrenomedullin is reduced during the late stage of sepsis. Biochim Biophys Acta 1427:315-321
86. Wang P, Yoo P, Zhou M, Cioffi WG, Ba ZF, Chaudry IH 1999 Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 85:59-65
87. Cui Y, Ji Y, Wu R, Zhou M, Wang P 2006 Adrenomedullin binding protein-1 is downregulated during polymicrobial sepsis in the rat. Int J Mol Med 17:925-929
88. Nagoshi Y, Kuwasako K, Cao YN, Imamura T, Kitamura K, Eto T 2004 Tumor necrosis factor-α downregulates adrenomedullin receptors in human coronary artery smooth muscle cells. Peptides 25:1115-1121
89. Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, Smith DM 2000 CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol 130:189-195
90. Nagae T, Mukoyama M, Sugawara A, Mori K, Yahata K, Kasahara M, Suganami T, Makino H, Fujinaga Y, Yoshioka T, Tanaka I, Nakao K 2000 Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun 270:89-93
91. Kitamuro T, Takahashi K, Totsune K, Nakayama M, Murakami O, Hida W, Shirato K, Shibahara S 2001 Differential expression of adrenomedullin and its receptor component, receptor activity modifying protein (RAMP) 2 during hypoxia in cultured human neuroblastoma cells. Peptides 22:1795-1801
92. Nikitenko LL, Smith DM, Bicknell R, Rees MC 2003 Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. FASEB J 17:1499-1501
93. Martinez A, Unsworth EJ, Cuttitta F 1996 Adrenomedullin-like immunoreactivity in the nervous system of the starfish Marthasterias glacialis. Cell Tissue Res 283:169-172
94. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju KH, Minamino N, Kangawa K, Ishikawa T, Fukuda M, Akimoto Y, Kawakami H, Imai T, Morita H, Yazaki Y, Nagai R, Hirata Y, Kurihara H 2001 Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104:1964-1971
95. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T 2002 Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105:106-111
96. Dackor RT, Fritz-Six K, Dunworth WP, Gibbons CL, Smithies O, Caron KM 2006 Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 26:2511-2518
97. Czyzyk TA, Ning Y, Hsu MS, Peng B, Mains RE, Eipper BA, Pintar JE 2005 Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev Biol 287:301-313
98. Di Iorio R, Marinoni E, Letizia C, Cosmi EV 2003 Adrenomedullin in perinatal medicine. Regul Pept 112:103-113
99. Wilson C, Nikitenko LL, Sargent IL, Rees MC 2004 Adrenomedullin: multiple functions in human pregnancy. Angiogenesis 7:203-212
100. Li M, Yee D, Magnuson T, Smithies O, Caron K 2006 Reduced maternal expression of adrenomedullin disrupts fertility, placentation and fetal growth in mice. J Clin Invest 116:2653-2662
101. Ishimitsu T, Tsukada K, Minami J, Ono H, Matsuoka H 2003 Variations of human adrenomedullin gene and its relation to cardiovascular diseases. Hypertens Res 26(Suppl):S129-S134
102. Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H 2003 Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 26(Suppl):S121-S127
103. Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, Ebihara A, Suematsu Y, Kangawa K, Hirata Y, Nagai R 2004 Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 109:1789-1794
104. Niu P, Shindo T, Iwata H, Ebihara A, Suematsu Y, Zhang Y, Takeda N, Iimuro S, Hirata Y, Nagai R 2003 Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. Hypertens Res 26:731-736
105. Nishimatsu H, Hirata Y, Shindo T, Kurihara H, Kakoki M, Nagata D, Hayakawa H, Satonaka H, Sata M, Tojo A, Suzucki E, Kangawa K, Matsuo H, Kitamura T, Nagai R 2002 Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury: studies on transgenic/knockout mice of adrenomedullin gene. Circ Res 90:657-663
106. Imai Y, Shindo T, Maemura K, Sata M, Saito Y, Kurihara Y, Akishita M, Osuga J, Ishibashi S, Tobe K, Morita H, Oh-hashi Y, Suzuki T, Maekawa H, Kangawa K, Minamino N, Yazaki Y, Nagai R, Kurihara H 2002 Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler Thromb Vasc Biol 22:1310-1315
107. Shindo T, Kurihara H, Maemura K, Kurihara Y, Kuwaki T, Izumida T, Minamino N, Ju KH, Morita H, Oh-hashi Y, Kumada M, Kangawa K, Nagai R, Yazaki Y 2000 Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 101:2309-2316
108. Tam CW, Husmann K, Clark NC, Clark JE, Lazar Z, Ittner LM, Gotz J, Douglas G, Grant AD, Sugden D, Poston L, Poston R, McFadzean I, Marber MS, Fischer JA, Born W, Brain SD 2006 Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res 98:262-270
109. Zhang JJ, Yoshida H, Chao L, Chao J 2000 Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Hum Gene Ther 11:1817-1827
110. Dobrzynski E, Wang C, Chao J, Chao L 2000 Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 36:995-1001
111. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F 1996 Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81:1449-1453
112. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, Miyamoto S, Dohi K, Minamino N, Shoji H, Kitamura K, Kangawa K, Matsuo H 1997 Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 25:953-957
113. Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamino N 1999 Adrenomedullin suppresses interleukin-1β-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett 463:110-114
114. Allaker RP, Zihni C, Kapas S 1999 An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 23:289-293